761 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Unknown  Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: nitroglycerin;   Drug: paclitaxel
22 Unknown  Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
Condition: Advanced Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Pemetrexed plus carboplatin
23 Recruiting INCB039110 in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Conditions: Carcinoma;   Non Small Cell Lung Cancer
Interventions: Drug: INCB039110;   Drug: erlotinib;   Drug: placebo
24 Recruiting Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Condition: Stage IIIA Non-small Cell Lung Cancer
Interventions: Radiation: proton beam radiation therapy;   Drug: cisplatin;   Drug: etoposide;   Procedure: therapeutic conventional surgery
25 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
26 Recruiting A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Condition: Squamous Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Standard of care treatment
27 Recruiting Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Squamous Cell
Interventions: Drug: Paclitaxel for Injection(Albumin Bound);   Drug: carboplatin;   Radiation: thoracic radiation therapy
28 Recruiting Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Procedure: EBUS-TBNA
29 Recruiting Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency
Condition: Non-small Cell Lung Cancer
Intervention: Drug: icotinib
30 Recruiting Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)
Conditions: Lung Cancer;   Non Small Cell Lung Cancer.
Interventions: Drug: Patritumab;   Drug: erlotinib:;   Drug: Placebo
31 Recruiting Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)
Condition: NSCLC Stage IIIA/B
Intervention: Other: Hsp70-peptide TKD/IL-2 activated, autologous NK cells
32 Not yet recruiting Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection
Conditions: Non-small Cell Lung Cancer Stage Ⅱ;   Non-small Cell Lung Cancer Stage ⅢA
Interventions: Drug: S1 capsule;   Drug: Vinorelbine
33 Recruiting Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)
Conditions: Non-Small Cell Lung Cancer;   Brain Metastases;   EGFR Gene Mutation
Interventions: Drug: Gefitinib;   Radiation: WBRT
34 Recruiting Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Stage IIIB;   Toxicity Due to Chemotherapy
Intervention: Device: chemotherapy & WBH
35 Recruiting Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Tarceva;   Radiation: Radiotherapy
36 Recruiting Efficacy and Safety Study of BIBW 2992 to Treat Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Afatinib (BIBW 2992)
37 Recruiting A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Dose escalation followed by treatment with MTD
38 Recruiting An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBF 1120;   Drug: Vinorelbine
39 Recruiting Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Nivolumab;   Drug: Gemcitabine;   Drug: Carboplatin
40 Recruiting The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer(NSCLC)
Condition: Oligo-metastatic Stage IV Non-small Cell Lung Cancer(NSCLC)
Interventions: Radiation: concurrent chemoradiotherapy;   Drug: Docetaxel;   Drug: pemetrexed;   Drug: Cisplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years